SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-243677
Filing Date
2023-09-27
Accepted
2023-09-27 16:07:59
Documents
14
Period of Report
2023-09-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d551529d8k.htm   iXBRL 8-K 31016
2 EX-99.1 d551529dex991.htm EX-99.1 13478
6 GRAPHIC g551529g0927092734200.jpg GRAPHIC 3006
  Complete submission text file 0001193125-23-243677.txt   182220

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA grts-20230927.xsd EX-101.SCH 2854
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20230927_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20230927_pre.xml EX-101.PRE 11710
8 EXTRACTED XBRL INSTANCE DOCUMENT d551529d8k_htm.xml XML 3464
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 231284823
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences